AGENT
Report
- Report Number
- 2134265-2021-00291
- Event Type
- Injury
- Date Received
- January 13, 2021
- Date of Event
- January 8, 2021
- Report Date
- March 9, 2021
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- LOX
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SN
- Reporter Occupation
- PHYSICIAN
Narratives
THE RETURNED PRODUCT CONSISTED OF AN AGENT (DCB) BALLOON CATHETER. THE SHAFT, HYPOTUBE, TIP AND BALLOON WERE MICROSCOPICALLY AND VISUALLY EXAMINED. THERE WAS CONTRAST IN THE INFLATION LUMEN AND BALLOON. THE BALLOON WAS LOOSELY FOLDED. THE DEVICE WAS SOAKED IN A WATER BATH FOR AN HOUR TO LOOSEN THE BLOOD AND CONTRAST IN THE DEVICE. THE DEVICE WAS PREPPED WITH AN INFLATION DEVICE FILLED WITH WATER AND CONNECTED TO THE INFLATION PORT TO INFLATE THE DEVICE. THE MARKER BANDS MEASURED AT 15MM FROM DISTAL TO PROXIMAL ENDS WHILE INFLATED AND DEFLATED. INSPECTION OF THE REMAINDER OF THE DEVICE PRESENTED NO OTHER DAMAGE OR IRREGULARITIES. PRODUCT ANALYSIS DID NOT CONFIRM THE REPORTED INCORRECT LENGTH.
IT WAS REPORTED THAT INCORRECT LENGTH OF A BALLOON AND OBSTRUCTION OCCURRED. A PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED ON THE OBTUSE MARGINAL 1 (OM1). A WOLVERINE CUTTING BALLOON WAS CHOSEN FOR FIRST INTERVENTION ON OM1. THE WOLVERINE WAS POSITIONED WITHIN THE LESION USING THE 2 RADIOPAQUE MARKERS AS REFERENCE. THE CUTTING BALLOON WAS INFLATED SLOWLY TO 15 ATMOSPHERES FOR 20 SECONDS. THE WOLVERINE WAS REMOVED FROM THE PATIENT. FOLLOWING REMOVAL OF THE WOLVERINE FROM THE PATIENT BODY, GLYCERYL TRINITRATE (GTN) 100MCG WAS GIVEN. THE NEXT INTERVENTION WAS TO DRUG ELUTING BALLOON (DEB). A 2.75MM X 15MM AGENT DCB BALLOON WAS ADVANCED AND INFLATED FOR 18 ATMOSPHERES FOR 47 SECONDS AT THE SAME LESION. UPON EXAMINATION OF CINE, BALLOON OVERHANG WAS NOTICED AFTER THE USE OF THE AGENT BALLOON. THE DEB WAS REMOVED AND GTN 100MCG WAS GIVEN. THE CINES FROM THE POST INTERVENTION SHOWED THAT THE OTHER BRANCH GOT PINCHED/NARROWED. THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED IN RELATION TO THIS EVENT AND THE PATIENT WAS STABLE FOLLOWING THE PROCEDURE. IT WAS FURTHER REPORTED THAT THE BALLOON WAS NOT BEING USED INSIDE A PREVIOUSLY PLACED STENT. THE LESION WAS 85% STENOSED WITH MILD TORTUOSITY AND MILD CALCIFICATION. THE OTHER BRANCH THAT WAS PINCHED/NARROWED WAS THE CIRCUMFLEX CORONARY ARTERY. THERE WERE NO PATIENT ISSUES RELATED TO THE VESSEL BEING PINCHED.
IT WAS REPORTED THAT INCORRECT LENGTH OF A BALLOON AND OBSTRUCTION OCCURRED. A PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED ON THE OBTUSE MARGINAL 1 (OM1). A WOLVERINE CUTTING BALLOON WAS CHOSEN FOR FIRST INTERVENTION ON OM1. THE WOLVERINE WAS POSITIONED WITHIN THE LESION USING THE 2 RADIOPAQUE MARKERS AS REFERENCE. THE CUTTING BALLOON WAS INFLATED SLOWLY TO 15 ATMOSPHERES FOR 20 SECONDS. THE WOLVERINE WAS REMOVED FROM THE PATIENT. FOLLOWING REMOVAL OF THE WOLVERINE FROM THE PATIENT BODY, GLYCERYL TRINITRATE (GTN) 100MCG WAS GIVEN. THE NEXT INTERVENTION WAS TO DRUG ELUTING BALLOON (DEB). A 2.75MM X 15MM AGENT DCB BALLOON WAS ADVANCED AND INFLATED FOR 18 ATMOSPHERES FOR 47 SECONDS AT THE SAME LESION. UPON EXAMINATION OF CINE, BALLOON OVERHANG WAS NOTICED AFTER THE USE OF THE AGENT BALLOON. THE DEB WAS REMOVED AND GTN 100MCG WAS GIVEN. THE CINES FROM THE POST INTERVENTION SHOWED THAT THE OTHER BRANCH GOT PINCHED/NARROWED. THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED IN RELATION TO THIS EVENT AND THE PATIENT WAS STABLE FOLLOWING THE PROCEDURE. IT WAS FURTHER REPORTED THAT THE BALLOON WAS NOT BEING USED INSIDE A PREVIOUSLY PLACED STENT. THE LESION WAS 85% STENOSED WITH MILD TORTUOSITY AND MILD CALCIFICATION. THE OTHER BRANCH THAT WAS PINCHED/NARROWED WAS THE CIRCUMFLEX CORONARY ARTERY. THERE WERE NO PATIENT ISSUES RELATED TO THE VESSEL BEING PINCHED.
IT WAS REPORTED THAT INCORRECT LENGTH OF A BALLOON AND OBSTRUCTION OCCURRED. A PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED ON THE OBTUSE MARGINAL 1 (OM1). A WOLVERINE CUTTING BALLOON WAS CHOSEN FOR FIRST INTERVENTION ON OM1. THE WOLVERINE WAS POSITIONED WITHIN THE LESION USING THE 2 RADIOPAQUE MARKERS AS REFERENCE. THE CUTTING BALLOON WAS INFLATED SLOWLY TO 15 ATMOSPHERES FOR 20 SECONDS. THE WOLVERINE WAS REMOVED FROM THE PATIENT. FOLLOWING REMOVAL OF THE WOLVERINE FROM THE PATIENT BODY, GLYCERYL TRINITRATE (GTN) 100MCG WAS GIVEN. THE NEXT INTERVENTION WAS TO DRUG ELUTING BALLOON (DEB). A 2.75MM X 15MM AGENT DCB BALLOON WAS ADVANCED AND INFLATED FOR 18 ATMOSPHERES FOR 47 SECONDS AT THE SAME LESION. UPON EXAMINATION OF CINE, BALLOON OVERHANG WAS NOTICED. THE DEB WAS REMOVED AND GTN 100MCG WAS GIVEN. THE CINES FROM THE POST INTERVENTION SHOWED THAT THE OTHER BRANCH GOT PINCHED. THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED IN RELATION TO THIS EVENT AND THE PATIENT WAS STABLE FOLLOWING THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 55062 | AGENT | CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS | LOX | BOSTON SCIENTIFIC CORPORATION | 3825 | 14165H19 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |